Lipocine doses first patient in BLOOM Phase 3 trial of oral brexanolone for postpartum depressionNov 10Trial updatebrexanoloneLipocine Inc.
Lipocine reports Q3 2026 results, highlights BLOOM study launch for LPCN 1154Nov 5Quarterly updateLipocine Inc.
Lipocine registers Phase 3 study of oral LPCN 1154A for postpartum depressionSep 16Trial updatebrexanoloneLipocine Inc.
Lipocine's PPD drug misses Phase 3 goal, but company cites site data anomaliesAug 4Quarterly updateLipocine Inc.